Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease.
Publication
, Journal Article
Buchheit, KM; Hacker, JJ; Gakpo, DH; Mullur, J; Sohail, A; Laidlaw, TM
Published in: Clin Exp Allergy
July 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Exp Allergy
DOI
EISSN
1365-2222
Publication Date
July 2021
Volume
51
Issue
7
Start / End Page
968 / 971
Location
England
Related Subject Headings
- SARS-CoV-2
- Middle Aged
- Male
- Humans
- Gene Expression Regulation, Enzymologic
- Female
- COVID-19 Drug Treatment
- COVID-19
- Aspirin
- Angiotensin-Converting Enzyme 2
Citation
APA
Chicago
ICMJE
MLA
NLM
Buchheit, K. M., Hacker, J. J., Gakpo, D. H., Mullur, J., Sohail, A., & Laidlaw, T. M. (2021). Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy, 51(7), 968–971. https://doi.org/10.1111/cea.13898
Buchheit, Kathleen M., Jonathan J. Hacker, Deborah H. Gakpo, Jyotsna Mullur, Aaqib Sohail, and Tanya M. Laidlaw. “Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease.” Clin Exp Allergy 51, no. 7 (July 2021): 968–71. https://doi.org/10.1111/cea.13898.
Buchheit KM, Hacker JJ, Gakpo DH, Mullur J, Sohail A, Laidlaw TM. Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy. 2021 Jul;51(7):968–71.
Buchheit, Kathleen M., et al. “Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease.” Clin Exp Allergy, vol. 51, no. 7, July 2021, pp. 968–71. Pubmed, doi:10.1111/cea.13898.
Buchheit KM, Hacker JJ, Gakpo DH, Mullur J, Sohail A, Laidlaw TM. Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy. 2021 Jul;51(7):968–971.
Published In
Clin Exp Allergy
DOI
EISSN
1365-2222
Publication Date
July 2021
Volume
51
Issue
7
Start / End Page
968 / 971
Location
England
Related Subject Headings
- SARS-CoV-2
- Middle Aged
- Male
- Humans
- Gene Expression Regulation, Enzymologic
- Female
- COVID-19 Drug Treatment
- COVID-19
- Aspirin
- Angiotensin-Converting Enzyme 2